PPLPHARMA vs RELIANCE
Head-to-head DCF comparison · Piramal Pharma Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
PPLPHARMA
Piramal Pharma Limited
Pharma
₹168
Above Fair ValueRELIANCE
Reliance Industries
Oil & Gas
₹1,308
Below Fair Value| Metric | PPLPHARMA | RELIANCE |
|---|---|---|
| Verdict | Above Fair Value | Below Fair Value |
| YieldIQ Score | 20/100 | 67/100 |
| Fair Value | ₹89 | ₹1,554 |
| Current Price | ₹168 | ₹1,308 |
| Discount to FV | -46.8% | +18.8% |
| Moat | None | Moderate |
| Piotroski F-Score | 4/9 | 4/9 |
| ROE | -4.0% | 8.9% |
| Debt / Equity | 0.60 | 0.37 |
| EV / EBITDA | 26.3× | 9.8× |
| Market Cap | ₹22,276 Cr | ₹17.70 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.